15 patents
Utility
Novel Therapeutic Uses of Mu-Opiate Receptor Peptides
6 Jul 23
The present invention pertains to novel uses of endomorphine-1 peptide, analogs, and salts thereof for therapy of children, patients currently suffering from drug addiction, patients prone to opioid addiction, and patients with chemo-induced pain.
Theodore E. MAIONE
Filed: 27 Dec 22
Utility
Analgesic mu-opioid receptor binding peptide pharmaceutical formulations and uses thereof
14 Mar 23
The subject invention provides compositions and methods for alleviating pain.
Theodore E. Maione, Constantine Basil Maglaris
Filed: 2 Oct 20
Utility
Advantageous Salts of Mu-opiate Receptor Peptides
13 Oct 22
The subject invention provides advantageous new salts of mu-opiate receptor peptides.
Theodore E. MAIONE
Filed: 17 Dec 21
Utility
Materials and Methods for Treatment of Inflammation
11 Aug 22
The subject invention pertains to peptides and salts thereof that are useful as anti-inflammatory agents and to compositions containing such peptides and salts as active ingredients.
THEODORE E. MAIONE, CONSTANTINE BASIL MAGLARIS
Filed: 21 Apr 22
Utility
Polymer Agonists of Mu Opioid Receptors
11 Aug 22
The subject invention provides compositions and methods for alleviating pain.
THEODORE E. MAIONE, JAMES HAMSHER, CONSTANTINE BASIL MAGLARIS
Filed: 20 Apr 22
Utility
Materials and methods for treatment of inflammation
10 May 22
The subject invention pertains to peptides and salts thereof that are useful as anti-inflammatory agents and to compositions containing such peptides and salts as active ingredients.
Theodore E. Maione, Constantine Basil Maglaris
Filed: 6 Aug 20
Utility
Advantageous Mu-opiate Receptor Peptide Compounds
9 Sep 21
The subject invention provides advantageous new salts of mu-opiate receptor peptides.
Theodore E. MAIONE
Filed: 24 May 21
Utility
Analgesic mu-opioid receptor binding peptide pharmaceutical formulations and uses thereof
13 Apr 21
The subject invention provides compositions and methods for alleviating pain.
Theodore E. Maione, Constantine Basil Maglaris
Filed: 25 Apr 18
Utility
Analgesic Mu-opioid Receptor Binding Peptide Pharmaceutical Formulations and Uses Thereof
21 Jan 21
The subject invention provides compositions and methods for alleviating pain.
Theodore E. MAIONE, Constantine Basil MAGLARIS
Filed: 2 Oct 20
Utility
Materials and Methods for Treatment of Inflammation
18 Nov 20
The subject invention pertains to peptides and salts thereof that are useful as anti-inflammatory agents and to compositions containing such peptides and salts as active ingredients.
THEODORE E. MAIONE, CONSTANTINE BASIL MAGLARIS
Filed: 5 Aug 20
Utility
Advantageous Salts of Mu-opiate Receptor Peptides
28 Oct 20
The subject invention provides advantageous new salts of mu-opiate receptor peptides.
Theodore E. MAIONE
Filed: 14 Jul 20
Utility
Novel Therapeutic Uses of Mu-opiate Receptor Peptides
21 Oct 20
The present invention pertains to novel uses of endomorphine-1 peptide, analogs, and salts thereof for therapy of children, patients currently suffering from drug addiction, patients prone to opioid addiction, and patients with chemo-induced pain.
Theodore E. MAIONE
Filed: 5 Jul 20
Utility
Polymer Agonists of Mu Opioid Receptors
26 Aug 20
The subject invention provides compositions and methods for alleviating pain.
THEODORE E. MAIONE, JAMES HAMSHER, CONSTANTINE BASIL MAGLARIS
Filed: 18 Nov 18
Utility
Materials and methods for treatment of inflammation
14 Oct 19
The subject invention pertains to peptides and salts thereof that are useful as anti-inflammatory agents and to compositions containing such peptides and salts as active ingredients.
Theodore E. Maione, Constantine Basil Maglaris
Filed: 12 Jul 18
Utility
Materials and Methods for Treatment of Inflammation
9 Oct 19
The subject invention pertains to peptides and salts thereof that are useful as anti-inflammatory agents and to compositions containing such peptides and salts as active ingredients.
THEODORE E. MAIONE, CONSTANTINE BASIL MAGLARIS
Filed: 23 Jun 19
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first